The neurology of folic acid deficiency

Handbook of Clinical Neurology

Volumn 120, Issue , 2014, Pages 927-943

  Reynolds, E H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aging; Dementia; Depression; Folic acid; Megaloblastic anemia; Methylation; Neuropathy

Indexed keywords

FOLIC ACID;

AGING; ARTICLE; DEMENTIA; DEPRESSION; FOLIC ACID DEFICIENCY; HUMAN; MEGALOBLASTIC ANEMIA; MENTAL DISEASE; METHYLATION; NEUROLOGIC DISEASE; NEUROLOGY; NEUROPATHY; VITAMIN B(12);

AGING; DEMENTIA; DEPRESSION; FOLIC ACID; MEGALOBLASTIC ANEMIA; METHYLATION; NEUROPATHY; VITAMIN B(12);

FOLIC ACID DEFICIENCY; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; NEUROLOGY;

EID: 84890837249     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4087-0.00061-9     Document Type: Chapter

References (146)

1. Ahrens R.S. Neurologic aspects of primary anaemia. Arch Neurol Psychiatry 1932, 28:92-109.
2. Folate in Health and Disease 1995, Marcel Dekker, New York. L.B. Bailey (Ed.).
3. Folate in Health and Disease 2010, CRC Press, Boca Raton. 2nd edn. L.B. Bailey (Ed.).
4. Berry R.J., Mulinare J., Hamner H.C. Folic acid fortification: neural tube defect risk reduction - a global perspective. Folate in Health and Disease 2010, 179-204. CRC Press, Boca Raton. L.B. Bailey (Ed.).
5. Bjelland I., Tell G.S., Vollset S.E., et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: the Hordaland homocysteine study. Arch Gen Psychiatry 2003, 60:618-625.
6. Blom H.J., Shaw G.M., den Heijer T., et al. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 2006, 7:724-731.
7. Folic Acid in Neurology, Psychiatry and Internal Medicine 1979, Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
8. Botez M.I., Fontaine F., Botez T., et al. Folate-responsive neurological and mental disorders: report of 16 cases. Eur Neurol 1977, 16:230-246.
9. Botez M.I., Peyronnard J.M., Charron L. Polyneuropathies responsive to folic acid therapy. Folic Acid in Neurology, Psychiatry and Internal Medicine 1979, 401-412. Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
10. Botez M.I., Botez T., Léveillé J., et al. Neuropsychological correlates of folic acid deficiency: facts and hypotheses. Folic Acid in Neurology, Psychiatry and Internal Medicine 1979, 435-461. Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
11. Bottiglieri T., Reynolds E. Folate in neurological disease: basic mechanisms. Folate in Health and Disease 2010, 355-380. CRC Press, Boca Raton. L.B. Bailey (Ed.).
12. Bottiglieri T., Godfrey P., Flynn T., et al. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990, 53:1096-1098.
13. Bottiglieri T., Hyland K., Laundy M., et al. Folate deficiency, biopterin and monoamine metabolism on depression. Psychol Med 1992, 22:871-876.
14. Bottiglieri T., Hyland K., Reynolds E.H. The clinical potential of ademethionine (S-adenosylmethionine) in neurological disorders. Drugs 1994, 48:1137-1152.
15. Bottiglieri T., Crellin R., Reynolds E.H. Folate and neuropsychiatry. Folate in Health and Disease 1995, 435-462. Marcel Dekker, New York. L.B. Bailey (Ed.).
16. Bottiglieri T., Reynolds E.H., Laundy M. Folate in CSF and Age. J Neurol Neurosurg Psychiatry 2000, 69:562.
17. Bottiglieri T., Laundy M., Crellin R., et al. Homocysteine, folate, methylation and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000, 69:228-232.
18. Cario H., Bode H., Debaton K.M., et al. Congenital null mutations of the FOLR1 gene: a progressive neurologic disease and its treatment. Neurology 2009, 73:2127-2129.
19. Homocysteine in Health and Disease 2001, Cambridge University Press, Cambridge. R. Carmel, D.W. Jacobsen (Eds.).
20. Carney M.W.P., Sheffield B.F. Associations of subnormal folate and vitaminB12 values and effects of replacement therapy. J Nerv Ment Dis 1970, 150:404-411.
21. Chanarin I. The Megaloblastic Anaemias 1969, Blackwell, Oxford.
22. Choumenkovitch S.F., Selhub J., Wilson P.W.F., et al. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002, 132:2792-2798.
23. Christensen K.E., Rozen R. Genetic variation: effect on folate metabolism and health. Folate in Health and Disease 2010, 75-110. CRC Press, Boca Raton. L.B. Bailey (Ed.).
24. Clarke R., Smith A.D., Jobst K.A., et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998, 55:1449-1455.
25. Clarke R., Collins R., Lewington S. Homocysteine and risk of heart disease and stroke: a meta-analysis. JAMA 2002, 288:2015-2022.
26. Clarke R., Grimley Evans J., Schneede J., et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004, 33:34-41.
27. Clarke R., Sherliker P., Hin H., et al. Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br J Nutr 2008, 100:1054-1059.
28. Coppen A., Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 2000, 60:121-130.
29. Coppen A., Chaudhry S., Swade C. Folic acid enhances lithium prophylaxis. J Affect Disord 1986, 10:9-13.
30. Crellin R., Bottiglieri T., Reynolds E.H. Folates and psychiatric disorders. Drugs 1993, 45:623-636.
31. Davis J., Watkins J.C. Facilitatory and direct excitatory effects of folate and folinate on single neurons of cat cerebral cortex. Biochem Pharmacol 1973, 22:1667-1668.
32. de Jager C.A., Oulhaj A., Jacoby R., et al. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomised controlled trial. Int J Geriatr Psychiatry 2012, 27:592-600.
33. den Heijer T., Vermeer S.E., Clarke R., et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003, 126:170-175.
34. Dhar M., Bellevue R., Carmel R. Pernicious anaemia with neuropsychiatric dysfunction in a patient with sickle cell anaemia treated with folate supplementation. N Engl J Med 2003, 348:2204-2207.
35. Dickinson C.J. Does folic acid harm people with vitamin B12 deficiency?. Q J Med 1995, 88:357-364.
36. Durga J., van Boxtel M.P.J., Schouten E.G., et al. Folate and the methylenetetrahydrofolate reductase 677C→T mutation correlate with cognitive performance. Neurobiol Aging 2006, 27:334-343.
37. Durga J., van Boxtel M.P.J., Schouten E.G., et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007, 369:208-216.
38. Durga J., van Boxtel M.P., Verhoef P., et al. Folate and ageing. Lancet 2007, 369:1601-1602.
39. Duthie S.J., Whalley L.J., Collins A.R., et al. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002, 75:908-913.
40. Fava M., Borus J.S., Alpert J.E., et al. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997, 154:426-428.
41. Fioravanti M., Ferrario E., Massaia M., et al. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr 1997, 26:1-13.
42. Friso S., Choi S.-W. Gene nutrient interactions and DNA methylation. J Nutr 2002, 132:2382S-2387S.
43. Fuso A., Seminara L., Cavallaro R.A., et al. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 2005, 28:195-204.
44. Fuso A., Nicolia V., Cavallaro R.A., et al. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteinemia, depletes brain S-adenosylmethionine, and enhances PSI and BACE expression and amyloid-beta deposition in mice. Mol Cell Neurosci 2008, 37:731-746.
45. Godfrey P.S.A., Toone B.K., Carney M.W.P., et al. Enhancement of recovery from psychiatric illness by methyl folate. Lancet 1990, 336:392-395.
46. Goodwin J.S., Goodwin J.M., Garry P.J. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983, 249:2917-2921.
47. Grant H.C., Hoffbrand A.V., Wells D.G. Folate deficiency and neurological disease. Lancet 1965, 2:763-767.
48. Hall B.E., Watkins C.H. Experience with pteroylglutamic (synthetic folic) acid in the treatment of pernicious anaemia. J Lab Clin Med 1947, 32:622-634.
49. Hassing L., Wahlin A., Winblad B., et al. Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning; a population-based study of healthy very old adults. Biol Psychiatry 1999, 45:1472-1480.
50. Healton E.B., Savage D.G., Brust J.C.M., et al. Neurologic aspects of cobalamin deficiency. Medicine 1991, 70:229-245.
51. Hernandez-Diaz S., Werler M.M., Walker A.M., et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000, 343:1608-1614.
52. Hibbard B.M. The role of folic acid in pregnancy, with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 1964, 71:529-542.
53. Hobbs C.A., Shaw G.M., Werler M., et al. Folate status and birth defect risk: epidemiological perspective. Folate in Health and Disease 2010, 133-153. CRC Press, Boca Raton. L.B. Bailey (Ed.).
54. Hommes O.R., Obbens E.A.M.T., Wijfels C.C.B. Epileptogenic activity of sodium-folate and the blood brain barrier in the rat. J Neurol Sci 1973, 19:63-71.
55. Hommes O.R., Hollinger J.L., Jansen M.J.T., et al. Convulsant properties of folate compounds; some considerations and speculations. Folic Acid in Neurology, Psychiatry and Internal Medicine 1979, 285-316. Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
56. Huemer M., Ausserer B., Graninger G., et al. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalised by folic acid supplementation. Epilepsia 2005, 46:1677-1683.
57. Irizarry M.C., Gurol M.E., Raju S., et al. Association of homocysteine with plasma amyloid β protein in aging and neurodegenerative disease. Neurology 2005, 65:1402-1408.
58. Iskandar B.J., Nelson A., Resnick D., et al. Folic acid supplementation enhances repair in the adult central nervous system. Ann Neurol 2004, 56:221-227.
59. Iskandar B.J., Rizk E., Meier B., et al. Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation. J Clin Invest 2010, 120:1603-1616.
60. Kalin S.R., Rimm E.B. Folate and vascular disease: epidemiological perspective. Folate in Health and Disease 2010, 263-290. CRC Press, Boca Raton. L.B. Bailey (Ed.).
61. Kim J.M., Stewart R., Kim S.W., et al. Changes in folate, vitamin B12 and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry 2008, 79:864-868.
62. Kinnier Wilson S.A. Neurology 1940, 1339-1358. Arnold, London.
63. Kronenberg G., Endres M. Neuronal injury: folate to the rescue?. J Clin Invest 2010, 120:1383-1386.
64. Kruman I.I., Kumaravel T.S., Lohani A., et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002, 22:1752-1762.
65. Layzer R.B. Myeloneurophathy after prolonged exposure to nitrous oxide. Lancet 1978, 2:1227-1230.
66. Leichtenstern O. Progressive perniciöse anämie bei tabeskranken. Dtsch Med Wochenschr 1884, 10:849-850.
67. Lewis S.J., Lawlor D.A., Davey Smith G., et al. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a metaanalysis. Mol Psychiatry 2006, 11:352-360.
68. Lichtheim L. Zur kenntniss der perniciösen anämie. Munch Med Wochenschr 1887, 34:301-306.
69. Lindenbaum J., Healton E.B., Savage D.G., et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anaemia or macrocytosis. N Engl J Med 1988, 318:1720-1728.
70. Lucock M. Is folic acid the ultimate functional food component for disease prevention?. BMJ 2004, 328:211-214.
71. Manzoor M., Runcie J. Folate-responsive neuropathy: a report of ten cases. BMJ 1976, 1:1176-1178.
72. Folate and Human Development 2002, Humana Press, Totowa, New Jersey. E.J. Massaro, J.M. Rogers (Eds.).
73. Mattson M.P., Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003, 26:137-146.
74. McCaddon A., Hudson P., Hill D., et al. Alzheimer's disease and total plasma aminothiols. Biol Psychiatry 2003, 53:254-260.
75. McIlroy S.P., Dynan K.B., Lawson J.T., et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002, 3:2351-2356.
76. Miller A.A., Goff D., Webster R.A. Predisposition of laboratory animals to epileptogenic activity of folic acid. Folic Acid in Neurology, Psychiatry and Internal Medicine 1979, 331-334. Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
77. Morris M.S. Homocysteine and Alzheimer's disease. Lancet Neurol 2003, 2:425-428.
78. Morris M.S., Jacques P.F. Folate and neurological function: epidemiological perspective. Folate in Health and Disease 2010, 325-353. CRC Press, Boca Raton. L.B. Bailey (Ed.).
79. Morris M.S., Jacques P.F., Rosenberg I.H., et al. Folate and vitamin B-12 status in relation to anaemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007, 85:193-200.
80. Morris M.S., Selhub J., Jacques P.F. Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the Framingham heart study. J Am Geriatr Soc 2012, 60:1457-1464.
81. Morrow J.I., Hunt S.J., Russell A.J., et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2009, 80:506-511.
82. MRC Vitamin Study Group Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991, 338:131-137.
83. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001, 357:169-175.
84. Nogales-Gaete J., Jiménez P.P., Garcia P.F., et al. Mielopatia por déficit de vitamina B12: caracterizatión clinica de 11 cases. Rev Med Chil 2004, 132:1377-1382. 2004.
85. Nunn J.F. Clinical aspects of the interaction between nitrous oxide and vitamin B12. Br J Anaesth 1987, 59:3-13. 1987.
86. Ogier de Baulny H., Gérard M., Saudubray J.M., et al. Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr 1998, 157:S77-S83.
87. Papakostas G.I., Petersen T., Lebowitz B.D., et al. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol 2005, 8:1-6.
88. Papakostas G.I., Shelton R.C., Zajecka J.M., et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression. Am J Psychiatry 2012, 169:1267-1274.
89. Passeri M., Cuciniotta D., Abate G., et al. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Ageing Clin Exp Res 1993, 5:63-71.
90. Pincus J.H. Folic acid deficiency: a cause of subacute combined degeneration. Folic Acid in Neurology, Psychiatry and Internal Medicine 1979, 427-433. Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
91. Pincus J.H., Reynolds E.H., Glaser G.H. Subacute combined system degeneration with folate deficiency. JAMA 1972, 221:496-497.
92. Prins N.D., den Heijer T., Hofman A., et al. Homocysteine and cognitive function in the elderly: the Rotterdam scan study. Neurology 2002, 59:1375-1380.
93. Ramaekers V.T., Blau N. Cerebral folate deficiency. Dev Med Child Neurol 2004, 46:843-851.
94. Ramaekers V.T., Rothenberg P., Sequeira J.M., et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 2005, 352:1985-1991.
95. Ramos M.I., Allen L.H., Haan M.N., et al. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr 2004, 80:1024-1028.
96. Ramos M.I., Allen L.H., Mungas D.M., et al. Low folate status is associated with impaired cognitive function and dementia in the Sacramento area Latino study on aging. Am J Clin Nutr 2005, 82:1346-1352.
97. Rampersaud G.C., Kauwell G.P.A., Hutson A.D., et al. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr 2000, 72:998-1003.
98. Ravaglia G., Forti P., Maioli F., et al. Homocystine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005, 82:636-643.
99. Ray J.G., Blom H.J. Vitamin B12 insufficiency and the risk of foetal neural tube defects. QJ Med 2003, 96:289-295.
100. Reynolds E.H. Mental effects of anticonvulsants, and folic acid metabolism. Brain 1968, 91:197-214.
101. Reynolds E.H. Neurological aspects of folate and vitamin B12 metabolism. Clinics in Haematology 1976, Vol. 5:661-696. Saunders, London. A.V. Hoffbrand (Ed.).
102. Reynolds E.H. Folic acid, vitamin B12 and the nervous system: historical aspects. Folic Acid in Neurology, Psychiatry, and Internal Medicine 1979, 1-5. Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
103. Reynolds E.H. Interrelationships between the neurology of folate and vitamin B12 deficiency. Folic Acid in Neurology, Psychiatry and Internal Medicine 1979, 501-515. Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
104. Reynolds E.H. Folic acid, ageing, depression, and dementia. BMJ 2002, 324:1512-1515.
105. Reynolds E.H. Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry 2002, 72:767-771.
106. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006, 5:949-960.
107. Reynolds E.H., Chanarin I., Matthews D.M. Neuropsychiatric aspects of anti-convulsant megaloblastic anaemia. Lancet 1968, 1:394-397.
108. Reynolds E.H., Preece J.M., Bailey J., et al. Folate deficiency in depressive illness. Br J Psychiatry 1970, 117:287-292.
109. Reynolds E.H., Gallagher B.B., Mattson R.H., et al. Relationship between serum and cerebrospinal fluid folate. Nature 1972, 240:155-157.
110. Reynolds E.H., Rothfeld P., Pincus J.H. Neurological disease associated with folate deficiency. BMJ 1973, 2:398-400.
111. Reynolds E.H., Carney M.W.P., Toone B.K. Methylation and mood. Lancet 1984, 2:196-198.
112. Rivey M.P., Schottelius D.D., Berg M.J. Phenytoin-folic acid: a review. Drug Intell Clin Pharm 1984, 18:292-301.
113. Rosenblatt D.S., Fenton W.A. Inherited disorders of folate and cobalamin transport and metabolism. The Metabolic Basis of Inherited Disease 2001, 3897-3933. McGraw-Hill, New York. 8th edn. C.S. Scriver, A.L. Beaudet, W.S. Sly (Eds.).
114. Rothenberg S.P., da Costa M.P., Sequeria J.M., et al. Auto-antibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med 2004, 350:134-142.
115. Russell J.S.R., Batten F.E., Collier J. Subacute combined degeneration of the spinal cord. Brain 1900, 23:39-110.
116. Sachdev P.S., Parslow R.A., Lux O., et al. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle aged community sample. Psychol Med 2005, 35:529-538.
117. Savage D.G., Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Bailliere's Clinical Haematology 1995, vol. 8:657-678. Bailliere Tindall.
118. Schwaninger M., Ringleb P., Winter R., et al. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia 1999, 40:345-350.
119. Schwartz S.O., Kaplan S.R., Armstrong B.E. The long-term evaluation of folic acid in the treatment of pernicious anaemia. J Lab Clin Med 1950, 35:894-898.
120. Scott J.M., Molloy A.M., Kennedy D.G., et al. Effects of the disruption of transmethylation in the central nervous system: an animal model. Acta Neurol Scand 1994, 154:27S-31S.
121. Selhub J., Morris M.S., Jacques P.F. In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Proc Natl Acad Sci U S A 2007, 104:19995-20000.
122. Serot J.M., Barbe F., Arning E., et al. Homocysteine and methylmolonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005, 76:1585-1587.
123. Seshadri S., Beiser A., Selhub J., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002, 346:476-483.
124. Shorvon S.D., Reynolds E.H. Folate deficiency and peripheral neuropathy. Folic Acid in Neurology, Psychiatry and Internal Medicine 1979, 413-421. Raven Press, New York. M.I. Botez, E.H. Reynolds (Eds.).
125. Shorvon S.D., Carney M.W.P., Chanarin I., et al. The neuropsychiatry of megaloblastic anaemia. BMJ 1980, 281:1036-1038.
126. Smithells R.W., Sheppard S., Schorah C.J., et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981, 56:911-918.
127. Sneath P., Chanarin I., Hodkinson H.M., et al. Folate status in a geriatric population and its relation to dementia. Age Ageing 1973, 2:177-182.
128. Snowdon D.A., Tully C.L., Smith C.D., et al. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the nun study. Am J Clin Nutr 2000, 71:993-998.
129. Spector R., Lorenzo A.V. Folate transport in the central nervous system. Am J Physiol 1975, 229:777-782.
130. Stabler S.P. Clinical folate deficiency. Folate in Health and Disease 2010, 409-428. CRC Press, Boca Raton. L.B. Bailey (Ed.).
131. Starr J.M., Pattie A., Whiteman M.C., et al. Vitamin B12, serum folate, and cognitive change between 11 and 79 years. J Neurol Neurosurg Psychiatry 2005, 76:291-292.
132. Steinfeld R., Grapp M., Kraetzner R., et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurogenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 2009, 85:354-363.
133. Strachan R.W., Henderson J.G. Dementia and folate deficiency. Q J Med 1967, 36:189-204.
134. Surtees R. Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr 1998, 157:118S-121S.
135. Surtees R. Cobalamin and folate responsive disorders. International Review of Child Neurology Series 2001, 96-108. MacKeith Press, London. P. Baxter (Ed.).
136. Surtees R., Leonard J., Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 1991, 338:1550-1554.
137. Tucker K.L., Qiao N., Scott T., et al. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005, 82:627-635.
138. van der Linden I.J., Afman L.A., Heil S.G., et al. Genetic variation in genes of folate metabolism and neural tube defect risk. Proc Nutr Soc 2005, 65:1-12.
139. van der Linden I.J., den Heijer M., Afman L.A., et al. The methionine synthase reductase 66A→G polymorphism is a maternal risk factor for spina bifida. J Mol Med 2006, 84:1047-1054.
140. Wahlin T.B.R., Wahlin A., Winblad B., et al. The influence of serum vitamin B12 and folate status on cognitive functioning in very old age. Biol Psychol 2001, 56:247-265.
141. Wallis D., Ballard J.L., Shaw G.M., et al. Folate-related birth defects: embryonic consequences of abnormal folate transport and metabolism. Folate in Health and Disease 2010, 155-178. CRC Press, Boca Raton. L.B. Bailey (Ed.).
142. Wang H.-X., Wahlin A., Basun H., et al. Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 2001, 56:1188-1194.
143. Waters A.H., Mollin D.L. Studies on the folic acid activity of human serum. J Clin Pathol 1961, 14:335-344.
144. Whitehead V.M. Acquired and inherited disorders of cobalamin and folate in children. Br J Haematol 2006, 134:125-136.
145. Wollack J.B., Makori B., Ahlawat S., et al. Characterisation of folate uptake by choroid plexus epithelial cells in a rat primary culture model. J Neurochem 2008, 104:1494-1503.
146. Woltmann H.W. The nervous symptoms in pernicious anaemia: an analysis of 150 cases. Am J Med Sci 1919, 157:400-409.